B
Basel Medical Group Ltd
NASDAQ:BMGL
Basel Medical Group Ltd
NASDAQ:BMGL
Price:
0.6399
USD
-5.92%
Market Closed
Market Cap:
$12m
Balance Sheet
Balance Sheet Decomposition
Basel Medical Group Ltd
Basel Medical Group Ltd
Balance Sheet Decomposition is not available for
Basel Medical Group Ltd
Basel Medical Group Ltd
Balance Sheet
Basel Medical Group Ltd
Basel Medical Group Ltd
Currency:
| Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
2
|
1
|
2
|
3
|
|
| Cash |
2
|
1
|
2
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
7
|
|
| Total Receivables |
14
|
13
|
12
|
2
|
|
| Accounts Receivables |
2
|
1
|
2
|
2
|
|
| Other Receivables |
12
|
12
|
11
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
0
|
|
| Total Current Assets |
16
|
15
|
16
|
13
|
|
| PP&E Net |
1
|
1
|
0
|
3
|
|
| PP&E Gross |
1
|
1
|
0
|
3
|
|
| Accumulated Depreciation |
1
|
1
|
1
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
|
| Total Assets |
17
N/A
|
15
-9%
|
16
+6%
|
17
+3%
|
|
| Liabilities | |||||
| Accounts Payable |
1
|
1
|
1
|
2
|
|
| Short-Term Debt |
4
|
3
|
3
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
2
|
|
| Other Current Liabilities |
2
|
2
|
4
|
6
|
|
| Total Current Liabilities |
7
|
6
|
7
|
11
|
|
| Long-Term Debt |
6
|
3
|
2
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
|
| Total Liabilities |
13
N/A
|
10
-25%
|
9
-12%
|
12
+37%
|
|
| Equity | |||||
| Common Stock |
0
|
0
|
24
|
34
|
|
| Retained Earnings |
4
|
5
|
17
|
29
|
|
| Other Equity |
0
|
0
|
0
|
0
|
|
| Total Equity |
4
N/A
|
5
+48%
|
8
+38%
|
5
-36%
|
|
| Total Liabilities & Equity |
17
N/A
|
15
-9%
|
16
+6%
|
17
+3%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
18
|
18
|
18
|
19
|
|
Switch to:
Switch to:
See Also
Discover More
